LobbyingNephron Pharmaceuticals lobbying by quarter
Nephron Pharmaceuticals's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Health Issues.
Nephron Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $45K | 1 |
| Q1 2023 | $0 | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $45K | 1 |
| Q3 2025 | $45K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$240K · 5 reports
- Health issues$22.5K · 1 reports
- Manufacturing$22.5K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)6 reports
- Commerce, Dept of (DOC)1 reports
- Defense, Dept of (DOD)1 reports
- Executive Office of the President (EOP)1 reports
- Food & Drug Administration (FDA)1 reports
- HOUSE OF REPRESENTATIVES1 reports
- Intl Trade Administration (ITA)1 reports
- SENATE1 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Vogel Group | $285K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALEXANDER NICHOLAS VOGEL sr | Former Chief Counsel, Senate Majority Leader Bill Frist | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | The Vogel Group | $50K |
| 04/20for Q1 | The Vogel Group | $50K |
| 01/19for Q4 2025 | The Vogel Group | $50K |
| 25/10/19for Q3 2025 | The Vogel Group | $45K |
| 25/07/20for Q2 2025 | The Vogel Group | $45K |
| 25/04/20for Q1 2025 | The Vogel Group | Under $5,000 |
| 25/04/07for Q2 2025 | The Vogel Group | Under $5,000 |
| 23/07/19for Q2 2023 | The Vogel Group | Under $5,000 |
| 23/04/17for Q1 2023 | The Vogel Group | Under $5,000 |
| 23/01/20for Q4 2022 | The Vogel Group | $45K |